TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+22.17%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$470M
AUM Growth
+$470M
(+48%)
Cap. Flow
+$90M
Cap. Flow
% of AUM
19.13%
Top 10 Holdings %
Top 10 Hldgs %
56.84%
Holding
48
New
14
Increased
13
Reduced
7
Closed
5
Top Buys
| 1 |
Medtronic
MDT
|
$14.4M |
| 2 |
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
|
$9.84M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
$9.78M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.59M |
| 5 |
Quest Diagnostics
DGX
|
$7.82M |
Top Sells
| 1 |
Bio-Rad Laboratories Class A
BIO
|
$7.73M |
| 2 |
AdaptHealth
AHCO
|
$6.65M |
| 3 |
Phreesia
PHR
|
$6.59M |
| 4 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$5.76M |
| 5 |
Plexus
PLXS
|
$3.55M |
Sector Composition
| 1 | Healthcare | 83.7% |
| 2 | Technology | 7.13% |
| 3 | Consumer Staples | 3.38% |
| 4 | Real Estate | 1.52% |
| 5 | Consumer Discretionary | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pacira BioSciences
PCRX
$1.2B
| $43.6M | 9.08% |
735,000
+80,000
| +12% | +$4.74M |
|
|
2
Medtronic
MDT
$119B
| $43.3M | 9.02% |
375,000
+125,000
| +50% | +$14.4M |
|
3
United Therapeutics
UTHR
$13.8B
| $28.1M | 5.86% |
183,000
+23,000
| +14% | +$3.53M |
|
4
Rigel Pharmaceuticals
RIGL
$697M
| $26M | 5.41% |
7,450,000
-50,000
| -0.7% | -$174K |
|
|
NUAN
5
DELISTED
Nuance Communications, Inc.
NUAN
| $25M | 5.21% |
575,000
+225,000
| +64% | +$9.78M |
|
|
MDRX
6
DELISTED
Veradigm Inc. Common Stock
MDRX
| $21.6M | 4.5% |
1,500,000
-400,000
| -21% | -$5.76M |
|
7
Labcorp
LH
$23.1B
| $20.4M | 4.25% |
100,000
+20,000
| +25% | +$4.08M |
|
8
Hologic
HOLX
$14.9B
| $20M | 4.16% |
275,000
-25,000
| -8% | -$1.82M |
|
|
9
Quest Diagnostics
DGX
$20.3B
| $19.8M | 4.13% |
165,000
+65,000
| +65% | +$7.82M |
|
10
AtriCure
ATRC
$1.84B
| $19.6M | 4.09% |
366,400
+16,400
| +5% | +$879K |
|
11
Perrigo
PRGO
$3.27B
| $16.6M | 3.47% |
375,000
-55,000
| -13% | -$2.44M |
|
12
Turning Point Brands
TPB
$1.79B
| $15.9M | 3.31% |
370,000
+165,000
| +80% | +$7.09M |
|
13
ICU Medical
ICUI
$3.15B
| $15.5M | 3.22% |
73,000
+12,000
| +20% | +$2.54M |
|
14
Lantheus
LNTH
$3.73B
| $13M | 2.72% |
950,000
| – | – |
|
15
RadNet
RDNT
$5.52B
| $12.1M | 2.52% |
650,000
+25,000
| +4% | +$465K |
|
16
SI-BONE Inc
SIBN
$719M
| $11.3M | 2.34% |
385,000
+140,000
| +57% | +$4.09M |
|
|
SNRHU
17
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
| $9.84M | 2.05% |
+950,000
| New | +$9.84M |
|
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $9.59M | 2% |
+42,000
| New | +$9.59M |
|
|
19
Phreesia
PHR
$1.88B
| $9.22M | 1.92% |
175,000
-125,000
| -42% | -$6.59M |
|
|
OPTN
20
DELISTED
OptiNose
OPTN
| $8.41M | 1.75% |
1,972,000
+122,000
| +7% | +$520K |
|
21
Viatris
VTRS
$12.3B
| $8.38M | 1.75% |
450,000
+400,000
| +800% | +$7.45M |
|
|
22
Plexus
PLXS
$3.7B
| $7.88M | 1.64% |
100,000
-45,000
| -31% | -$3.55M |
|
23
Opendoor
OPEN
$3.27B
| $7.16M | 1.49% |
+450,000
| New | +$7.16M |
|
|
STRM
24
DELISTED
Streamline Health Solutions
STRM
| $6.93M | 1.44% |
4,305,882
| – | – |
|
|
LMNX
25
DELISTED
Luminex Corp
LMNX
| $6.05M | 1.26% |
+250,000
| New | +$6.05M |
|